DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Olpha
03 12Granules India Limited
04 2Adamed Pharma
05 1Alhavi Pharma
06 2Alkem Laboratories
07 2Annora Pharma
08 1Aurobindo Pharma Limited
09 40Boehringer Ingelheim GmbH
10 6Farmaprojects S.A.U
11 3Grupo Azevedos
12 4Intas Pharmaceuticals
13 1InvaGen Pharmaceuticals Inc
14 2Kinapse
15 2MSN Laboratories
16 1Mahban Group
17 4Pharmaline
18 3Pluviaendo
19 3Prinston
20 3Sun Pharmaceutical Industries Limited
21 4Sunshine Lake Pharma
22 2Tecnimede
23 3Varian Pharmed
24 3Viatris
25 4XYZ Pharma
26 4Zentiva
27 4Zydus Pharmaceuticals
01 6Antic-calc Tablet, Film Coated
02 4Extended ReleaseTablet
03 3FILM COATED PILL
04 14Film Coated Tablet
05 4Film Coated Tablet
06 3Filmtabl
07 7Filmtable
08 6Immediate Release Tablet
09 1Linagliptin 5Mg 28 Combined Oral Use
10 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
11 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
12 4Oral Solid Dosage Form
13 2Pellets
14 4TABLET
15 6TABLET, EXTENDED RELEASE;ORAL
16 4TABLET; ORAL
17 33TABLET;ORAL
18 11Tablet
19 2Tablets
20 1Tablets
21 2tablet
22 2Blank
01 4DISCN
02 1Dossier Readiness: Q1 2025
03 2Generic
04 4Lead Market Dossiers- Filed
05 4Prescription
06 8ROW
07 4ROW, US
08 17RX
09 77Blank
01 3EMPAGLIFLOZIN AND LINAGLIPTIN
02 6EMPAGLIFLOZIN; LINAGLIPTIN
03 2GLYXAMBI
04 2Glyxambi
05 6JENTADUETO
06 2JENTADUETO XR
07 14Jentadueto
08 5LINAGLIPTIN
09 1LINAGLIPTIN 5
10 14LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
11 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
12 1Melijent
13 1TRADJENTA
14 1TRAJENTA
15 4TRIJARDY XR
16 8Trajenta
17 48Blank
01 2Australia
02 4Canada
03 4Czech Republic
04 20India
05 5Iran
06 3Italy
07 1Latvia
08 4Lebanon
09 6Norway
10 2Poland
11 5Portugal
12 6Spain
13 3Sweden
14 10Switzerland
15 3Turkey
16 43USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Empagliflozin; Linagliptin; Metformin
Brand Name :
Dosage Form : Extended ReleaseTablet
Dosage Strength : 5MG; 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Empagliflozin; Linagliptin; Metformin
Brand Name :
Dosage Form : Extended ReleaseTablet
Dosage Strength : 10MG; 5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Empagliflozin; Linagliptin; Metformin
Brand Name :
Dosage Form : Extended ReleaseTablet
Dosage Strength : 12.5MG; 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Empagliflozin; Linagliptin; Metformin
Brand Name :
Dosage Form : Extended ReleaseTablet
Dosage Strength : 25MG; 5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW, US
Registration Country : India
Brand Name :
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW, US
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Brand Name :
Dosage Form : Pellets
Dosage Strength : 2.78%; 5.56%
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Brand Name :
Dosage Form : Pellets
Dosage Strength : 2.78%; 13.89%
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 208415
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GLYXAMBI
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG;5MG
Packaging :
Approval Date : 2015-01-30
Application Number : 206073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 5MG;1GM
Packaging :
Approval Date : 2016-05-27
Application Number : 208026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-08-31
Application Number : 208335
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2021-08-30
Application Number : 208336
Regulatory Info : RX
Registration Country : USA
